Qureos
SEAPORTS THERAPEUTICS

SEAPORTS THERAPEUTICS

Domain / Industry not specified
LocationUnited States
Company SizeN/A

About Company

Seaport Therapeutics (Nasdaq: SPTX) is a clinical-stage biopharmaceutical company focused on developing novel oral medicines for neuropsychiatric disorders like depression and anxiety. Spun out of PureTech Health, the Boston-based company went public in May 2026, raising $254.9 million in an upsized initial public offering

© 2026 Qureos. All rights reserved.